Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 5Neoplasms 3Prostatic Neoplasms 2Pain, Postoperative 2Pain 2Neuroma 2Chronic Pain 2Breast Diseases 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Skin Diseases 1Rectal Neoplasms 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Neoplasms by Site 1Muscular Atrophy 1Muscle Spasticity 1Lower Urinary Tract Symptoms 1Low Anterior Resection Syndrome 1Head and Neck Neoplasms 1Gastroparesis 1Ganglion Cysts 1Esophageal Neoplasms 1Esophageal Motility Disorders 1Esophageal Diseases 1Esophageal Achalasia 1Cluster Headache 1Brain Injuries 1

Interventions

Cisplatin 141Radiotherapy 115Cetuximab 95Docetaxel 69Radiotherapy, Intensity-Modulated 55Carboplatin 47pembrolizumab 46Surveys and Questionnaires 46Paclitaxel 41Fluorouracil 39Radiation 29Blood Specimen Collection 27Drug Therapy 26Erlotinib Hydrochloride 23Nivolumab 21Surgical Procedures, Operative 17Standard of Care 16Magnetic Resonance Spectroscopy 16Radiosurgery 14Pemetrexed 14Gemcitabine 14Everolimus 13Celecoxib 13durvalumab 12Low-Level Light Therapy 12Immunohistochemistry 12Cyclophosphamide 12Capecitabine 12Amifostine 12Chemoradiotherapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Head and Neck Neoplasms × Botulinum Toxins, Type A × Clear all
NCT06530524 2024-07-31

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Not yet recruiting
50 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡